Company Number: 14328432

Analysis Date: 2025-07-20 11:03 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   JS Therapy Limited is a micro private limited company operating in human health activities, with a single controlling shareholder/director. The company shows positive net assets and working capital, indicating an ability to meet short-term obligations. However, the declining net assets and current assets year-over-year, coupled with dividend payments despite no employees or apparent revenue growth, raise concerns about cash retention for operational needs. Given the limited financial history (incorporated in 2022) and lack of profitability data, credit approval should be conditional upon ongoing monitoring of cash flows and receipt of updated management accounts to confirm sustainable operations and debt servicing capacity.

2. Financial Strength:
   The company maintains positive net assets (£4,025 as of 2024) and net current assets (£4,066), suggesting a solvent balance sheet. Fixed assets are minimal (£759) and declining, typical for a service business. However, net assets decreased by approximately 40.7% from £6,787 in 2023 to £4,025 in 2024, primarily due to reduced current assets and increased accruals/deferred income (£800). The payment of £19,921 in dividends despite limited asset base may have weakened equity reserves, impacting financial resilience. There is no indication of external borrowings or long-term liabilities, which reduces financial gearing risk.

3. Cash Flow Assessment:
   Current assets (£8,159) exceed current liabilities (£4,093), providing a current ratio of roughly 2.0, which is adequate for liquidity. However, the decline in current assets from £9,907 to £8,159 and increase in accruals suggest tighter cash flow management or delayed receipts. Absence of employees indicates low operating overheads but also potential reliance on director input or outsourced services. The dividend payout relative to net assets could strain liquidity if cash inflows are inconsistent. Overall, short-term liquidity appears sufficient but warrants close cash flow monitoring.

4. Monitoring Points:

• Track quarterly cash flow statements and management accounts to ensure sufficient liquidity for operational needs.
• Monitor dividend distributions relative to retained earnings and cash reserves to avoid equity erosion.
• Observe any increase in liabilities or delays in receivables that may impact working capital.
• Confirm ongoing business activity and revenue generation given no employees reported and limited asset base.
• Review director conduct and company filings to ensure compliance and absence of regulatory issues.